"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"
NCT ID: NCT04030013
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
210 participants
INTERVENTIONAL
2015-05-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Diabetes is a chronic disease that requires lifelong self care behavior. Successful treatment of chronic diseases is closely associated with the education of both patients and their relatives. Patient education is one of the most important responsibilities of diabetes nurse educators. In the management of diabetes, helping patients to improve their health and quality of life is considered an important aspect of diabetes self-care education. Solid organ transplantation is now the standard of care for end-stage organ failure. New-onset diabetes mellitus after solid organ transplantation (NODAT) has emerged as an increasingly important determinant of outcomes and survival in transplant recipients. Patient education and self-management are crucial for ensuring successful outcome post transplantation. No adequate studies concerning education of diabetic renal transplants.
Aim of the work: The aim of this work is to evaluate the effect of diabetes education given to renal transplant recipients with new onset diabetes after transplantation (NODAT) on their self-care activities and metabolic control variables and reversibility of the present chronic diabetic complications.
Patients and methods:
The study will involve 210 diabetic renal transplant patients (NODAT) who will be referred from Hamed Al-Essa organ transplant center to Dasman Diabetes Institute. These patients will be sub-divided into three subgroups: patients who will receive group education (n=70) will represent group1, patients who will receive one to one education (n=70) will represent group 2, while those who will receive the conventional (not structured) education program will serve as control group 3(n= 70). All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Expected outcome: Patient education given to transplant recipients with NODAT could affect patients' self-care activities, metabolic control positively and possibly help in reversal of chronic diabetic complications
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Self-Management Educational Program
NCT05581264
PROmoting Diabetes Education and Management Through Peer Support and Team Referral
NCT05587348
Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
NCT06984133
Community Health Workers and Diabetes Education
NCT02811874
Identification and Treatment of Diabetes In Solid Organ Transplant Recipients
NCT02605200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data collection tools
Patient identification form:
This form will include information about the patient's identifying characteristics such as age, gender, education status and disease-related information such as duration of the disease and the treatments management of diabetes.
Metabolic control parameters form:
This form will include patient's metabolic control variables such as HbA1c, lipids (Total cholesterol, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL), renal and liver function tests. Metabolic control parameters will be measured in Hamed Al-Essa organ transplantation center (OTC) outpatient clinic and will be sent with each patient to Dasman Diabetes Institute within one week of patient evaluation for starting educational program.
Blood pressure, height, weight, body mass index and waist circumference of patients will be measured and recorded by the researcher each time by using the same measurement device and method. Patients' waist circumferences will be measured midway between costal margin and iliac crests by a measuring tape in standing position, over underwear and after slight expiration.
Diabetes self-care scale (DSCS) The Arabic translated 24-items scale- developed in English by Lee and Fisher(41) which measures the self care of patients with diabetes -will be applied to patients before and after the education program.
Data collection method In the pretest phase of the research, patients will be given a patient identification form, metabolic control parameters form and a DSCS. The forms will be completed within15-25 minutes by the patients in the presence of the researcher. Telephone numbers and addresses of patients will be taken for proper communication if needed.
Patient education Group education sessions will be carried out in special halls in Dasman Diabetes Institute (DDI) after proper coordination with the randomly selected patients (group 1) (6-10 patients in each education group). Patients of one to one education group (group 2) will receive education sessions individually in closed education clinics of DDI. The first session will last for 60 minutes then the next sessions will last for 30 minutes. The content of education will be repeated entirely or partly by the researcher according to each patient's needs. Mixed education techniques such as description, question and answer techniques will be used as an education method and feedback will be stimulated trying to enable patients to understand their self-care management independently. Refreshment education sessions will be delivered every 3 months later on till the end of the study.
Regarding patients of the third group (control group), each patient will receive the conventional (non-structured) education program in their mother hospital (OTC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group education for 2 years
Patients who will receive structured diabetes education in groups , Group 1
group education
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
One to one education for 2 years
Patients who will receive one to one structured diabetes education, Group 2
group education
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Control group without structured education
Patients who will not receive structured diabetes education, Group 3
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group education
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dasman Diabetes Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nashwa Othman
Senior specialist diabetes educator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nashwa F Othman, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Senior diabetes educator in Dasman Diabetes Institute
Osama A Gheith, MD PhD
Role: STUDY_DIRECTOR
Consultant nephrologist, Hamed Al-Essa organ transplnat center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dasman diabetes institute
Kuwait City, Kuwait City, Kuwait
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RA 2014-049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.